Tweet
Terrific, thanks so much for sending this. Besides actually saying that they're still optimistic, he seems to speak concretely about its eventual release. Can't say I'm in love with the 2020 estimate (although it would seem to confirm that the company is not inclined to create false hopes, which would make it the opposite of almost all the other companies working in this area), but with the new clinical trial starting in the 3rd quarter of this year, I guess we'll at least have something to follow again fairly soon.